News
-
SineuGene’s SNUG01 AAV Gene Therapy Granted FDA Orphan Drug Designation for ALS
Jun 26 2025 -
Genevector’s JWK002 AAV Gene Therapy for X-Linked Retinoschisis Receives NMPA IND Approval
Jun 25 2025 -
NeuExcell Therapeutics Announce First Patient Dosed in Clinical Trial for Alzheimer’s Gene Therapy
Jun 12 2025 -
Starrygene’s AAV Bispecific Antibody Gene Therapy for wAMD Advances to Phase II with Support from PackGene
May 25 2025 -
PackGene Biotech Supports Patient Family-Driven World’s First GM2 AB Variant Gene Therapy Clinical Trial
May 15 2025 -
PackGene to Showcase Scalable AAV Manufacturing, AI-Driven Capsid Engineering, and End-to-End CDMO Solutions at ASGCT 2025
May 12 2025 -
Guangzhou First People’s Hospital Successfully Administers Southern China’s First Gaucher Disease Gene Therapy
Mar 03 2025 -
Rett Syndrome Gene Therapy Study Shows Positive Results, PackGene Aids AAV Development
Feb 14 2025 -
A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefining What’s Possible in Gene Therapy with Help from Weill Cornell Medicine
Jan 08 2025